Concepedia

Chris S Busse

CS

3

Publications

396

Citations

3

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

General Atomics (United States)

Chris S Busse is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2002–2004

3

Publications

3

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

Chris S Busse, Jesse Brodkin, David Tattersall et al. · Neuropsychopharmacology · 2004 · 157 citations · Full text

, , +11

Anxiolytic-like activity of the mGluR5 antagonist MPEPA comparison with diazepam and buspirone

Jesse Brodkin, Chris S Busse, Stacey J. Sukoff Rizzo et al. · Pharmacology Biochemistry and Behavior · 2002 · 144 citations

, , +7

Reduced stress‐induced hyperthermia in mGluR5 knockout mice

Jesse Brodkin, Margaret Bradbury, Chris S Busse et al. · European Journal of Neuroscience · 2002 · 95 citations

Rows per page

1–3 of 3